IS7394A - Stöðugar lyfjasamsetningar - Google Patents

Stöðugar lyfjasamsetningar

Info

Publication number
IS7394A
IS7394A IS7394A IS7394A IS7394A IS 7394 A IS7394 A IS 7394A IS 7394 A IS7394 A IS 7394A IS 7394 A IS7394 A IS 7394A IS 7394 A IS7394 A IS 7394A
Authority
IS
Iceland
Prior art keywords
formulations
earth metal
drug formulations
stable drug
metal carbonate
Prior art date
Application number
IS7394A
Other languages
English (en)
Other versions
IS2440B (is
Inventor
Eyjolfsson Reynir
Original Assignee
Actavis Group Hf.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actavis Group Hf. filed Critical Actavis Group Hf.
Priority to IS7394A priority Critical patent/IS2440B/is
Publication of IS7394A publication Critical patent/IS7394A/is
Publication of IS2440B publication Critical patent/IS2440B/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IS7394A 2002-01-15 2004-08-11 Samsetningar af kínapríli og skyldum ACE-hindrum IS2440B (is)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IS7394A IS2440B (is) 2002-01-15 2004-08-11 Samsetningar af kínapríli og skyldum ACE-hindrum

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IS6233 2002-01-15
PCT/IS2003/000002 WO2003059388A1 (en) 2002-01-15 2003-01-14 Formulations of quinapril and related ace inhibitors
IS7394A IS2440B (is) 2002-01-15 2004-08-11 Samsetningar af kínapríli og skyldum ACE-hindrum

Publications (2)

Publication Number Publication Date
IS7394A true IS7394A (is) 2004-08-11
IS2440B IS2440B (is) 2008-11-15

Family

ID=36701209

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7394A IS2440B (is) 2002-01-15 2004-08-11 Samsetningar af kínapríli og skyldum ACE-hindrum

Country Status (10)

Country Link
US (1) US20050118259A1 (is)
EP (1) EP1513555B1 (is)
AT (1) ATE357933T1 (is)
AU (1) AU2003235579A1 (is)
DE (1) DE60312857T2 (is)
EA (1) EA007981B1 (is)
ES (1) ES2283774T3 (is)
IS (1) IS2440B (is)
UA (1) UA78542C2 (is)
WO (1) WO2003059388A1 (is)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005027881A2 (en) * 2003-09-23 2005-03-31 Texcontor Etablissement Stable quinapril compositions
WO2005067887A2 (en) * 2004-03-24 2005-07-28 Actavis Group Formulations of ramipril
PT1729739T (pt) * 2004-03-29 2016-12-01 Servier Lab Processo para a preparação de uma composição farmacêutica sólida
SI21800A (sl) 2004-05-14 2005-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nov postopek sinteze perindoprila
GB0518129D0 (en) * 2005-09-06 2005-10-12 Arrow Int Ltd Ramipril formulation
GB2431579A (en) * 2005-10-28 2007-05-02 Arrow Int Ltd Ramipril formulations
US20070098782A1 (en) * 2005-10-28 2007-05-03 Selamine Limited Ramipril Formulation
ES2523729T3 (es) 2006-06-16 2014-12-01 Lek Pharmaceuticals D.D. Composición farmacéutica que comprende hidroclorotiazida y telmisartán
GB0624087D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril combination salt
GB0624090D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amine salts
GB0624082D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril metal salts
GB0624084D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amino acid salts
WO2008132756A1 (en) * 2007-05-01 2008-11-06 Lupin Limited Stable pharmaceutical compositions of ramipril
TR200906322A2 (tr) 2009-08-17 2011-07-21 Bi̇lgi̇ç Mahmut Çözünürlük ve stabilite özellikleri geliştirilmiş granüller.
PL227900B1 (pl) 2012-11-15 2018-01-31 Adamed Spolka Z Ograniczona Odpowiedzialnoscia Kompozycja farmaceutyczna zawierająca inhibitor ACE i bloker kanałów wapniowych, sposób jej wytwarzania i jednostka dawkowania zawierająca tę kompozycję

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4743450A (en) * 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
HU222489B1 (hu) * 1990-07-25 2003-07-28 Novartis Ag. Stabilizált gyógyszerkészítmények és eljárás az előállításukra
US5292520A (en) * 1990-09-13 1994-03-08 Akzo N.V. Stabilized solid pharmaceutical composition containing acid addition salts of a basic drug and an alkaline stabilizer
US5573780A (en) * 1995-08-04 1996-11-12 Apotex Usa Inc. Stable solid formulation of enalapril salt and process for preparation thereof
EP1083931B1 (en) * 1998-06-05 2005-05-11 Warner-Lambert Company LLC Stabilization of compositions containing ace inhibitors using magnesium oxide
JP2002529405A (ja) * 1998-11-06 2002-09-10 ジー・ディー・サール・アンド・カンパニー 心臓血管系疾患による発病率及び死亡率減少のためのアンギオテンシン変換酵素阻害薬及びアルドステロン拮抗薬の併用療法
RU2165251C1 (ru) * 2000-09-06 2001-04-20 Федеральное государственное унитарное предприятие Московское производственное химико-фармацевтическое объединение им. Н.А. Семашко Твердая лекарственная форма эналаприла и способ ее получения

Also Published As

Publication number Publication date
US20050118259A1 (en) 2005-06-02
AU2003235579A1 (en) 2003-07-30
EA007981B1 (ru) 2007-02-27
DE60312857D1 (de) 2007-05-10
ES2283774T3 (es) 2007-11-01
EA200400942A1 (ru) 2004-12-30
UA78542C2 (en) 2007-04-10
EP1513555A1 (en) 2005-03-16
WO2003059388A1 (en) 2003-07-24
DE60312857T2 (de) 2008-01-17
IS2440B (is) 2008-11-15
ATE357933T1 (de) 2007-04-15
EP1513555B1 (en) 2007-03-28

Similar Documents

Publication Publication Date Title
IS2440B (is) Samsetningar af kínapríli og skyldum ACE-hindrum
ATE374016T1 (de) Tablette mit hohem wirkstoffgehalt
DE60331153D1 (de) Reboxetin enthaltende tablette mit verzögerter wirkstoffabgabe
WO2001078680A3 (en) Pharmaceutical compositions comprising fluvastatin
EP1589947B8 (en) Pharmaceutical formulation with an insoluble active agent for pulmonary administration
EA201001083A1 (ru) Композиция таблетки пролонгированного высвобождения, содержащая прамипексол или его фармацевтически приемлемую соль, способ ее изготовления и ее применение
AU2003274681A1 (en) Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release
DE60028754D1 (de) Feste dispersion mit ritonavir, fenofibrat oder griseofulvin
AR018143A1 (es) Formulacion para preparar un comprimido de desintegracion rapida, comprimidos de desintegracion rapida, especialmente comprimidos de desintegracionrapida en la boca
AR038527A1 (es) Forma de dosificacion que contiene un inhibidor de la pde 4 como ingrediente activo
WO2001076574A3 (en) Novel medical use of aldosterone synthase inhibitors alone or in combination with at1-receptor antagonists
AU2002335046A1 (en) The use of proton sequestering agents in drug formulations
EP1346732A3 (en) Dosage forms for hygroscopic active ingredients
TW200609005A (en) Film-coated tablet with plural coating-layers
MY133322A (en) Storage stable tablets of fosinopril sodium
WO2005067887A3 (en) Formulations of ramipril
WO2006050054A3 (en) Compounds and methods of use thereof
WO2006071844A8 (en) Oxygen-impervious packaging and methods for storing thyroid hormone
WO2006097943A3 (en) Pharmaceutical compositions of amlodipine and benazepril
DK1200088T3 (da) Sammensætning indeholdende paracetamol og drotaverin
NO20054417L (no) Fremgangsmate for fremstilling av farmasoytiske preperater i form av fibratholdige tabletter og de derved fremstilte tabletter
DK1423109T3 (da) Præparater som omfatter pektin og ascorbinsyre
CR8948A (es) Composicion farmaceutica
WO2005115346A3 (en) Pharmaceutical composition containing risperidone
CR8973A (es) Composicion farmaceutica en forma de una forma de dosificacion solida soluble en agua